Therapeutic agents and methods
US11040037B2 · kind B2 · utility
8Cited by
10References
6Claims
0Family size
Inventors
Key dates
| Filing date | Oct 3, 2017 |
| Grant date | Jun 22, 2021 |
| Priority date | — |
| Expiry date | Mar 16, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides glucocorticoid receptor antagonists for treatment of infection, neoplasia, and fatty liver disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.